Other conditions & injuries

PPID in horses: coat changes, hormone testing and long-term care

Pituitary pars intermedia dysfunction, or PPID, is an age-related neuroendocrine disorder in horses and other equids. Delayed shedding or a persistent long coat is a strong clue, while muscle loss, altered sweating, recurrent infections and other changes can occur. Diagnosis and treatment require clinical context and appropriately interpreted hormone tests. Insulin dysregulation must be assessed separately because it strongly influences laminitis risk and feeding decisions.

Updated 1,151 words · 6 min read6 sources · scope listed below
A horse in a fenced pasture

A horse in a fenced pasture. Species or setting illustration; this is not a photograph of a diagnosed case or of the reader’s animals. It shows one representative host species for a broader multi-species topic; it does not imply this is the only species affected. Credit and license details are linked below.

Parco Naturale Tre Cime horses 3.jpg · kallerna · CC BY-SA 4.0 · Full credit & reuse terms

Reading the sources

This reference uses the specific documents linked in the article and listed below. Check their scope, publication dates and the statements they support.

PPID affects hormonal control rather than being ordinary aging

Progressive loss of dopaminergic control from the hypothalamus allows the intermediate part of the pituitary gland to enlarge and release excess peptide hormones. The clinical syndrome is more accurately called PPID than equine Cushing’s disease because it differs from the classic cortisol-centered disorders described in some other species.

Age increases the likelihood, but age alone is not a diagnosis. A horse may have several simultaneous geriatric problems, and not every change in weight, activity or coat should be attributed to the pituitary. The practical aim is to identify a treatable contributor to declining function while continuing to investigate other causes of discomfort or poor condition.

Source: Recommendations for diagnosis and management of pituitary pars intermedia dysfunction; Hypertrichosis associated with adenomas of the pars intermedia in horses; Pituitary pars intermedia dysfunction.

Delayed shedding is informative, but the clinical spectrum is wider

An unusually persistent or patchy coat can precede a generalized long, sometimes curling hair coat. Changes in sweating, loss of topline muscle, reduced activity, a rounded abdomen, increased drinking or urination and recurrent infections may also occur. These findings vary and are not all present in every patient.

Pay attention to a pattern developing across seasons rather than one cold-weather photograph. Muscle loss should not automatically be interpreted as a need for unrestricted grain, and lethargy may also reflect pain, anemia or other disease. A sudden severe change, fever, colic, inability to eat or new neurologic signs needs timely investigation rather than waiting for a scheduled endocrine recheck.

Source: Hypertrichosis associated with adenomas of the pars intermedia in horses; Recommendations for diagnosis and management of pituitary pars intermedia dysfunction; Pituitary pars intermedia dysfunction.

Hormone results are interpreted with age, signs and season

Baseline ACTH and, when appropriate, ACTH response to TRH are practical diagnostic tools. Neither should be treated as a universal pass/fail number independent of the patient. Season, breed, assay and clinical circumstances influence results, and there is overlap between healthy and affected populations.

Current guidance uses clinical probability and interpretive ranges, with repeat assessment or additional testing when findings conflict. A mildly abnormal result in a young horse without convincing signs has different meaning from the same result in an older horse with characteristic changes. The veterinarian and laboratory should use the relevant method and local seasonal interpretation rather than a cutoff copied from a different hemisphere or analyzer.

Source: BEVA primary care clinical guidelines: diagnosis and management of equine pituitary pars intermedia dysfunction; Recommendations for diagnosis and management of pituitary pars intermedia dysfunction; Hypertrichosis associated with adenomas of the pars intermedia in horses.

Insulin assessment changes the laminitis and feeding plan

PPID and EMS are separate disorders that can coexist. A horse with PPID can have normal insulin regulation or clinically important insulin dysregulation. The latter increases concern for hyperinsulinemia-associated laminitis and often changes grazing and ration choices.

Do not assume that successful pituitary treatment makes the feet safe. A painful short stride or reluctance to turn needs prompt veterinary assessment and appropriate hoof care. Conversely, do not impose severe carbohydrate and calorie restriction on every thin PPID horse if insulin regulation is normal. The ration should match body condition, dental function, muscle loss and measured metabolic status.

Source: Recommendations for diagnosis and management of pituitary pars intermedia dysfunction; BEVA primary care clinical guidelines: diagnosis and management of equine pituitary pars intermedia dysfunction; Equine metabolic syndrome; Equine metabolic syndrome testing.

Pergolide is a treatment for control, not a one-time cure

Veterinary treatment commonly uses pergolide to replace part of the missing dopaminergic restraint on the pituitary. Many horses improve clinically, but the disease generally requires ongoing management. The prescription and any adjustment should account for the horse’s response, other illness and the relevant product information.

Some horses have reduced appetite when treatment starts or changes. Report this promptly rather than allowing a vulnerable older horse to lose intake or changing the dose repeatedly without guidance. If clinical signs remain poor despite apparently improved hormone results, investigate alternative or concurrent disease. An improved laboratory number is useful information, but the patient’s comfort and function remain central.

Source: Recommendations for diagnosis and management of pituitary pars intermedia dysfunction; BEVA primary care clinical guidelines: diagnosis and management of equine pituitary pars intermedia dysfunction; Hypertrichosis associated with adenomas of the pars intermedia in horses.

Daily care should solve practical problems

A retained coat can impair comfort in warm conditions, so suitable clipping and weather protection may be helpful. Dentistry and accessible, appropriate feed matter when muscle loss or reduced chewing affects intake. Hoof care addresses metabolic risk and ordinary age-related foot problems, while infections and wounds should receive timely assessment.

Notice whether the horse eats comfortably, maintains a suitable condition, moves willingly and interacts normally. A caretaker who knows what normal looks like can recognize a meaningful deterioration. Persistent pain or loss of normal activity deserves assessment even if the endocrine test appears well controlled.

Source: Recommendations for diagnosis and management of pituitary pars intermedia dysfunction; Hypertrichosis associated with adenomas of the pars intermedia in horses; Pituitary pars intermedia dysfunction.

Follow-up combines clinical response with useful testing

A treatment plan should specify when response is assessed and which clinical changes matter for that horse. Current guidance emphasizes improvement in the patient, using endocrine reassessment as appropriate. Evidence remains limited about exactly how particular monitoring strategies improve long-term outcomes, so test-driven dose escalation should not replace clinical judgment.

Many affected horses can maintain a good quality of life, though concurrent laminitis or other chronic disease may dominate the outlook. Do not stop or intensify treatment solely because the coat looks better or one result remains mildly abnormal. Discuss the balance of symptoms, appetite, function, hormone interpretation and other diagnoses with the veterinarian, adjusting the plan to what actually benefits the animal.

Source: BEVA primary care clinical guidelines: diagnosis and management of equine pituitary pars intermedia dysfunction; Recommendations for diagnosis and management of pituitary pars intermedia dysfunction.

Practical questions

Does a long coat always mean PPID?

It is a strong clue, especially with delayed shedding in an older equid, but clinical context and appropriate assessment remain necessary.

Must every PPID horse lose weight?

No. Some are thin or losing muscle. Feeding should account for insulin regulation, body condition and dental function rather than follow one restrictive diet.

Does PPID treatment eliminate laminitis risk?

No. Insulin dysregulation and existing hoof injury need their own management and follow-up.

Related animal-health reading

Cite this reference

LivestockDefense. “PPID in horses: coat changes, hormone testing and long-term care.” Updated 2026-11-02. https://livestockdefense.com/threats/pituitary-pars-intermedia-dysfunction-in-horses/

Add the date you accessed the page. This identifies the current reference; keep a permitted saved copy if your work depends on its exact wording. A citation alone does not establish support for a claim.

How to cite a page and its revision ↗

Sources & boundaries

Read the evidence in context.

These documents support the statements identified in this reference. Check their scope and dates when deciding whether they answer your question.

  1. Merck Veterinary Manual: Equine metabolic syndrome

    Source update: 2025-08. Most recent check: 2026-11-02.

    Insulin dysregulation, lean phenotype, laminitis risk and individualized diet/hoof/exercise care; no oral challenge protocol, numerical test cutoff or drug dose reproduced.

  2. Cornell University Animal Health Diagnostic Center: Equine metabolic syndrome testing

    Source update: Not provided. Most recent check: 2026-11-02.

    Laboratory testing context and EMS/PPID coexistence; no hormone sampling or challenge-test protocol reproduced.

  3. Equine Endocrinology Group: Recommendations for diagnosis and management of pituitary pars intermedia dysfunction

    Source update: 2025-10. Most recent check: 2026-11-02.

    Current working-group recommendations, age-related neuroendocrine mechanism, context-specific testing and clinical response, individualized nutrition and wellness. No test cutoffs, drug doses, administration alternatives or detailed collection protocol reproduced.

  4. British Equine Veterinary Association / Equine Veterinary Journal: BEVA primary care clinical guidelines: diagnosis and management of equine pituitary pars intermedia dysfunction

    Source update: 2024. Most recent check: 2026-11-02.

    GRADE evidence appraisal of clinical probability, test limits, pergolide response and uncertainty in monitoring outcomes; no treatment dose or test protocol reproduced.

  5. Merck Veterinary Manual: Hypertrichosis associated with adenomas of the pars intermedia in horses

    Source update: 2025-05. Most recent check: 2026-11-02.

    PPID clinical spectrum, endocrine diagnosis, insulin-associated laminitis risk and coat-care support; no dose or universal high-cortisol explanation.

  6. UC Davis Center for Equine Health: Pituitary pars intermedia dysfunction

    Source update: Not provided. Most recent check: 2026-11-02.

    Clinical context and PPID/EMS distinction only; current testing and management are anchored to the newer EEG and BEVA guidance.

Full source register ↗